Cytokine Storm Management in Severe COVID-۱۹: Exploring Four Effective Medicinal Plants as Potential Interventions

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 33

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TIPS-9-4_006

تاریخ نمایه سازی: 22 اردیبهشت 1403

چکیده مقاله:

COVID-۱۹, caused by the SARS-CoV-۲ virus, has emerged as a global health threat. Due to coronovirus mutations and genetic variations, effective treatments remain elusive. Currently, the primary strategy for disease management revolves around coronovirus vaccines, representing the sole avenue for disease control. A prominent factor in the pathogenesis of COVID-۱۹ is the severe inflammation triggered by a phenomenon known as cytokine storm. This review delves into the pivotal role of interleukin-۶ (IL-۶) in orchestrating the cytokine storm and explores the intricate network of signaling pathways and inhibitors, including phytochemicals. Numerous clinical trials have explored the potential of anti-cytokine agents and medicinal plants with cytokine-modulating attributes in COVID-۱۹ patients. According to various studies investigating the effects of medicinal plants on COVID-۱۹, four specific plants—Silybum marianum L., Tanacetum parthenium L., Curcuma longa L., and Zingiber officinale Rosc.—have exhibited significant anti-IL-۶ signaling properties. However, further rigorous clinical data are needed to establish their prophylactic or therapeutic efficacy. Overall, both in-vivo and clinical studies suggest that the aforementioned medicinal plants, endowed with proven anti-inflammatory and immune-modulatory properties, particularly through IL-۶ reduction, could make valuable contributions to the management of COVID-۱۹.

نویسندگان

Mina Shafiee

Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Samira Sadat Abolmaali

Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Mohsen Salmanpour

Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Ehsan Amiri

Department of Phytopharmaceuticals (Traditional Pharmacy), Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

Alimohammad Tamaddon

Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Velavan TP, Meyer CG. The COVID-۱۹ epidemic. Trop Med Int ...
  • Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as ...
  • Samadi M, Shirvani H, Rahmati-Ahmadabad S. A study of possible ...
  • Beltrán-García J, Osca-Verdegal R, Pallardó FV, Ferreres J, Rodríguez M, ...
  • Quirch M, Lee J, Rehman S. Hazards of the Cytokine ...
  • Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. ...
  • Acter T, Uddin N, Das J, Akhter A, Choudhury TR, ...
  • Alimardani V, Abolmaali SS, Tamaddon AM. Recent Advances on Nanotechnology-Based ...
  • Mehta N, Mazer-Amirshahi M, Alkindi N, Pourmand A. Pharmacotherapy in ...
  • Viana J, van Dorp CH, Nunes A, Gomes MC, van ...
  • Bahrami M, Kamalinejad M, Latifi SA, Seif F, Dadmehr M. ...
  • Locht C. Vaccines against COVID-۱۹. Anaesth Crit Care Pain Med. ...
  • Huang C, Wang Y, Li X, Ren L, Zhao J, ...
  • Dzobo K, Chiririwa H, Dandara C, Dzobo W. Coronavirus Disease-۲۰۱۹ ...
  • Cunningham L, Kimber I, Basketter DA, McFadden JP. Why judiciously ...
  • Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- ...
  • Hunter CA, Jones SA. IL-۶ as a keystone cytokine in ...
  • Murray PJ. STAT۳-mediated anti-inflammatory signalling. Biochem Soc Trans. ۲۰۰۶ Dec;۳۴(Pt ...
  • Gholijani N, Abolmaali SS, Kalantar K, Ravanrooy MH. Therapeutic Effect ...
  • Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and ...
  • Portsmore S, Tran Nguyen TN, Beacham E, Neelakantan P. Combined ...
  • Crisafulli S, Isgrò V, La Corte L, Atzeni F, Trifirò ...
  • Alsaffar DF. In Silico Molecular Docking Studies of Medicinal Arabic ...
  • Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, ...
  • Shafiee M, Abolmaali S, Abedanzadeh M, Abedi M, Tamaddon A. ...
  • Son Y, Lee HJ, Rho JK, Chung SY, Lee CG, ...
  • Tian L, Li W, Wang T. Therapeutic effects of silibinin ...
  • Musazadeh V, Karimi A, Bagheri N, Jafarzadeh J, Sanaie S, ...
  • Pareek A, Suthar M, Rathore GS, Bansal V. Feverfew (Tanacetum ...
  • Wang M, Li Q. Parthenolide could become a promising and ...
  • Abedanzadeh M, Salmanpour M, Farjadian F, Mohammadi S, Tamaddon AM. ...
  • Thota SM, Balan V, Sivaramakrishnan V. Natural products as home-based ...
  • Avasarala S, Zhang F, Liu G, Wang R, London SD, ...
  • Ahmadi S, Mehrabi Z, Zare M, Ghadir S, Masoumi SJ. ...
  • Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. ...
  • Silveira D, Prieto-Garcia JM, Boylan F, Estrada O, Fonseca-Bazzo YM, ...
  • Vahdat Shariatpanahi Z, Mokhtari M, Taleban FA, Alavi F, Salehi ...
  • Rajagopal K, Byran G, Jupudi S, Vadivelan R. Activity of ...
  • Mesri M, Esmaeili Saber SS, Godazi M, Roustaei Shirdel A, ...
  • نمایش کامل مراجع